We are live on ! Find out more
MGP

M&G plc Portfolio holdings

AUM $20.1B
1-Year Est. Return 16.62%
This Fund
S&P 500
This Quarter Est. Return
-0.47%
1 Year Est. Return
+16.62%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$19.4B
AUM Growth
-$107M
Cap. Flow
+$1.01M
Cap. Flow %
0.01%
Top 10 Hldgs %
31.82%
Holding
423
New
51
Increased
131
Reduced
125
Closed
43

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$811M
2
MSFT icon
Microsoft
MSFT
+$183M
3
INTU icon
Intuit
INTU
+$152M
4
AVGO icon
Broadcom
AVGO
+$130M
5
MICC
The Magnum Ice Cream Company N.V.
MICC
+$102M

Top Sells

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$190M
2
ELV icon
Elevance Health
ELV
+$109M
3
CME icon
CME Group
CME
+$92.3M
4
BMY icon
Bristol-Myers Squibb
BMY
+$79.9M
5
HTHT icon
Huazhu Hotels Group
HTHT
+$67.8M

Sector Composition

Rank Sector Weight
1 Technology 20.57%
2 Healthcare 16.38%
3 Consumer Discretionary 15.42%
4 Financials 11.36%
5 Communication Services 6.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NTAP icon
151
NetApp
NTAP
$37.2B
$14M 0.07%
+137,421
New +$13.9M
FTAI icon
152
FTAI Aviation
FTAI
$22.2B
$14M 0.07%
+57,151
New +$15.1M
CRGO icon
153
Freightos
CRGO
$65.6M
$13.7M 0.07%
6,871,094
– –
DY icon
154
Dycom Industries
DY
$12.3B
$13.3M 0.07%
39,360
+443
+1% +$166K
ATRO icon
155
Astronics
ATRO
$3.84B
$13.3M 0.07%
+238,448
New +$14.4M
GILD icon
156
Gilead Sciences
GILD
$165B
$13.3M 0.07%
95,757
-6,689
-7% -$937K
FLUT icon
157
Flutter Entertainment
FLUT
$16.4B
$13.1M 0.07%
+128,271
New +$18.5M
TCOM icon
158
Trip.com Group
TCOM
$29.1B
$13.1M 0.07%
261,593
+40,410
+18% +$2.36M
TXRH icon
159
Texas Roadhouse
TXRH
$13.7B
$12.9M 0.07%
78,002
-2,299
-3% -$413K
DB icon
160
Deutsche Bank
DB
$71.5B
$12.9M 0.07%
445,054
+427,241
+2,398% +$15M
MBLY icon
161
Mobileye
MBLY
$2.2B
$12.8M 0.07%
+1,825,912
New +$16.5M
ZBH icon
162
Zimmer Biomet
ZBH
$18.4B
$12.7M 0.07%
141,610
+18,408
+15% +$1.69M
BMRN icon
163
BioMarin Pharmaceuticals
BMRN
$12.3B
$12.7M 0.07%
226,541
+2,398
+1% +$140K
TRI icon
164
Thomson Reuters
TRI
$44.1B
$12.5M 0.06%
+135,472
New +$14.3M
ALNY icon
165
Alnylam Pharmaceuticals
ALNY
$29.3B
$12.5M 0.06%
+37,656
New +$12.8M
RYAN icon
166
Ryan Specialty Holdings
RYAN
$5.55B
$12.4M 0.06%
+365,841
New +$15.6M
WDAY icon
167
Workday
WDAY
$44.4B
$12.4M 0.06%
+95,416
New +$15.1M
WING icon
168
Wingstop
WING
$3.18B
$12.4M 0.06%
+79,995
New +$19.2M
VOYA icon
169
Voya Financial
VOYA
$9.19B
$12.3M 0.06%
181,554
-2,581
-1% -$187K
NBIX icon
170
Neurocrine Biosciences
NBIX
$16.6B
$12.2M 0.06%
92,554
+955
+1% +$127K
ROKU icon
171
Roku
ROKU
$22.7B
$12.1M 0.06%
+127,026
New +$12.4M
RYTM icon
172
Rhythm Pharmaceuticals
RYTM
$7.96B
$12.1M 0.06%
138,567
+1,493
+1% +$145K
CCEP icon
173
Coca-Cola Europacific Partners
CCEP
$47.9B
$12M 0.06%
131,481
+14,638
+13% +$1.41M
SNOW icon
174
Snowflake
SNOW
$115B
$11.9M 0.06%
78,665
+71,098
+940% +$13.2M
VEEV icon
175
Veeva Systems
VEEV
$37.4B
$11.9M 0.06%
67,418
+64,343
+2,092% +$12.6M
5 6
7
8 9

Similar funds

OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
HHII
H&H International Investment Palo Alto, California $20B AUM 9.66% 1-Year Est. Return
EWA
EP Wealth Advisors Torrance, California $20.3B AUM
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
BG
Bahl & Gaynor Cincinnati, Ohio $19.8B AUM 19.53% 1-Year Est. Return
NIM
NEOS Investment Management Westport, Connecticut $19.8B AUM 31.12% 1-Year Est. Return

M&G plc's Q1 2026 Portfolio in Review

As of Q1 2026, M&G plc held 423 positions worth $19.4B, down 0.55% from $19.5B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

M&G plc's Q1 2026 filing shows 51 new, 131 increased, 125 reduced and 43 closed positions. Its largest new stake was AstraZeneca: 4,204,199 shares worth $817M. The largest sale was Lam Research, an estimated $190M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • M&G plc's largest Q1 2026 buy was AstraZeneca: 4,204,199 shares worth $817M.
  • M&G plc added most to Microsoft in Q1 2026, an estimated $183M increase.
  • M&G plc's biggest Q1 2026 reduction was Lam Research, cutting an estimated $190M.
  • M&G plc fully exited Crown Castle in Q1 2026, selling an estimated $34M.
  • M&G plc's ten largest holdings make up 32% of its $19.4B portfolio in Q1 2026.
  • M&G plc opened 51 new positions and closed 43 in Q1 2026.
  • M&G plc's portfolio value fell 0.55% quarter-over-quarter to $19.4B.

Based on M&G plc's 13F filing for Q1 2026, filed 13 May 2026.